|
Volumn 32, Issue 10, 2008, Pages 1636-1637
|
JAK-2V617F mutation in RARS-t: A target for Imatinib therapy?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ERYTHROPOIETIN;
IMATINIB;
JANUS KINASE 2;
PROTEIN TYROSINE KINASE;
AGED;
ASTHENIA;
BLOOD CELL COUNT;
BLOOD TRANSFUSION;
BONE MARROW BIOPSY;
CASE REPORT;
DISEASE COURSE;
DRUG TARGETING;
ENZYME ACTIVITY;
FEMALE;
FOLLOW UP;
HUMAN;
LETTER;
MUTATION;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS;
THROMBOCYTE COUNT;
AGED;
AMINO ACID SUBSTITUTION;
ANEMIA, REFRACTORY;
ANTINEOPLASTIC AGENTS;
FEMALE;
HUMANS;
JANUS KINASE 2;
PIPERAZINES;
PLATELET COUNT;
POINT MUTATION;
PROTEIN KINASE INHIBITORS;
PYRIMIDINES;
|
EID: 44749087319
PISSN: 01452126
EISSN: None
Source Type: Journal
DOI: 10.1016/j.leukres.2008.03.008 Document Type: Letter |
Times cited : (4)
|
References (5)
|